Related Experiment Video
Updated: Jan 23, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long non-coding RNA IQCJ-SCHIP1 antisense RNA 1 is downregulated in colorectal cancer and inhibits cell proliferation
Jia Zhang1,2, Zehua Bian1, Guoying Jin1
1Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi 214062, China.
Background:
IQCJ-SCHIP1 antisense RNA 1 (IQCJ-SCHIP1-AS1) was a functional novel long non-coding RNA (lncRNA) revealed by our previous expression profile. In this study, we aim to investigate its clinical relevance and biological significance in colorectal cancer (CRC).
Methods:
We measured the expression levels of IQCJ-SCHIP1-AS1 in 86 paired CRC tissues using quantitative RT-PCR assay, and then analyzed its association with patient prognoses. Moreover, gain-of-function and loss-of-function studies were performed to examine the biological functions of IQCJ-SCHIP1-AS1. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene set enrichment analysis (GSEA) were used to elucidate potential mechanisms of IQCJ-SCHIP1-AS1 in CRC.
Results:
More than 2-fold decreased expression of IQCJ-SCHIP1-AS1 was found in half of CRC tissues (53.5%, 46/86). IQCJ-SCHIP1-AS1 down-regulation was correlated with poor differentiation (P=0.025), advanced depth of tumor (P=0.022), lymphatic invasion (P=0.010), advanced tumor stage (P=0.006), and poor prognosis (P=0.0027) in CRC patients. The Cox proportional hazards model demonstrated that IQCJ-SCHIP1-AS1 expression was an independent prognostic factor for CRC (HR =0.247, 95% CI: 0.081-0.752, P=0.014). Moreover, knockdown of IQCJ-SCHIP1-AS1 promoted CRC cell proliferation through increasing cell cycle progression and impairing cell apoptosis. Additionally, bioinformatics analysis showed that differential expression genes in IQCJ-SCHIP1-AS1-depleted CRC cells were enriched in the pathways of cell cycle, DNA replication, and p53.
Conclusions:
Our results demonstrate that IQCJ-SCHIP1-AS1 has an indicative tumor suppressor role and appears to be a potential prognostic factor in CRC for the first time.
Insights
The long non-coding RNA IQCJ-SCHIP1-AS1 is downregulated in colorectal cancer (CRC) and acts as a tumor suppressor. Its reduced expression correlates with poor prognosis, indicating its potential as a prognostic biomarker for CRC patients.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- IQCJ-SCHIP1 antisense RNA 1 (IQCJ-SCHIP1-AS1) is a novel long non-coding RNA (lncRNA) identified in previous expression profiling.
- The clinical relevance and biological significance of IQCJ-SCHIP1-AS1 in colorectal cancer (CRC) remain largely unexplored.
Purpose of the Study:
- To investigate the clinical relevance of IQCJ-SCHIP1-AS1 in colorectal cancer (CRC).
- To elucidate the biological significance and potential mechanisms of IQCJ-SCHIP1-AS1 in CRC progression.
Main Methods:
- Quantitative RT-PCR was used to measure IQCJ-SCHIP1-AS1 expression in 86 paired CRC tissues.
- Gain-of-function and loss-of-function studies were conducted to assess the biological roles of IQCJ-SCHIP1-AS1.
- Bioinformatic analyses including Gene Ontology (GO), KEGG, and GSEA were employed to explore underlying mechanisms.
Main Results:
- IQCJ-SCHIP1-AS1 was downregulated in 53.5% of CRC tissues and significantly correlated with poor differentiation, advanced tumor depth, lymphatic invasion, and advanced tumor stage.
- Reduced IQCJ-SCHIP1-AS1 expression was associated with poor prognosis in CRC patients and identified as an independent prognostic factor.
- Knockdown of IQCJ-SCHIP1-AS1 promoted CRC cell proliferation, cell cycle progression, and impaired apoptosis, with associated gene expression enriched in cell cycle and DNA replication pathways.
Conclusions:
- IQCJ-SCHIP1-AS1 exhibits a tumor suppressor role in colorectal cancer.
- IQCJ-SCHIP1-AS1 serves as a potential prognostic biomarker for colorectal cancer.
Related Concept Videos
RNA Splicing
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
RNA Stability
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...

